MARKET

BCYC

BCYC

Bicycle Therapeutics Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.68
-0.31
-3.09%
Closed 16:00 10/11 EDT
OPEN
9.67
PREV CLOSE
9.99
HIGH
9.98
LOW
9.14
VOLUME
9.92K
TURNOVER
--
52 WEEK HIGH
14.91
52 WEEK LOW
6.24
MARKET CAP
41.95M
P/E (TTM)
-5.5371
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BCYC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BCYC News

  • Bicycle Therapeutics Announces Presentation of Updated Data from Phase I/IIa Trial Evaluating BT1718 in Patients with Advanced Solid Tumors at ESMO 2019
  • Benzinga.09/28 22:19
  • Bicycle Therapeutics Announces Presentation of Updated Data from Phase I/IIa Trial Evaluating BT1718 in Patients with Advanced Solid Tumors at ESMO 2019 Annual Congress
  • Business Wire.09/28 11:00
  • Bicycle Therapeutics to Present Updated Data from Phase I/IIa Trial Evaluating Lead Asset BT1718 in Patients with Advanced Solid Tumors at ESMO 2019 Annual Congress
  • Business Wire.09/24 11:00
  • 46 Biggest Movers From Yesterday
  • Benzinga.09/20 08:45

More

Industry

Biotechnology & Medical Research
+0.89%
Pharmaceuticals & Medical Research
+0.89%

Hot Stocks

Name
Price
%Change

About BCYC

Bicycle Therapeutics PLC, formerly Bicycle Therapeutics Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing a class of medicines for diseases. The Company’s lead product candidate, BT1718, is a Bicycle Toxin Conjugate (BTC) for oncology indications. BT1718 targets tumors that express Membrane Type 1 matrix metalloprotease (MT1-MMP). The Company is also developing BT5528 and BT8009, which are BTCs targeting Ephrin type-A receptor 2 (EphA2), and Nectin-4, for oncology indications. The Company is also developing cytotoxic T-cell activators, designed to trigger an immune response to tumors.
More

Webull offers Bicycle Therapeutics PLC (ADR) (BCYC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.